{
  "id": 17842062,
  "title": "WuXi Biologics, Fresenius partner ahead of biosimilar boom",
  "url": "https://urgent.news/2026/11/02/wuxi-biologics-fresenius-partner-ahead-of-biosimilar-boom",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-02T18:44:22.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/wuxi-biologics-fresenius-partner-ahead-of-biosimilar-boom/"
  },
  "original_language": "en",
  "account": null,
  "summary": "WuXi Biologics and German drugmaker Fresenius have reached one of the largest biosimilar deals to date ahead of what some in the industry have called an upcoming “golden decade” for such products. ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}